Exact Mass: 245.129

Exact Mass Matches: 245.129

Found 173 metabolites which its exact mass value is equals to given mass value 245.129, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Glutaminylvaline

(2S)-2-{[(2S)-2-amino-1-hydroxy-4-(C-hydroxycarbonimidoyl)butylidene]amino}-3-methylbutanoate

C10H19N3O4 (245.1375)


Glutaminylvaline is a dipeptide composed of glutamine and valine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Asparaginylisoleucine

(2S,3S)-2-{[(2S)-2-amino-1-hydroxy-3-(C-hydroxycarbonimidoyl)propylidene]amino}-3-methylpentanoate

C10H19N3O4 (245.1375)


Asparaginylisoleucine is a dipeptide composed of asparagine and isoleucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Valylglutamine

(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-carbamoylbutanoic acid

C10H19N3O4 (245.1375)


Valylglutamine is a dipeptide composed of valine and glutamine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Isoleucyl-Asparagine

2-[(2-Amino-1-hydroxy-3-methylpentylidene)amino]-3-(C-hydroxycarbonimidoyl)propanoate

C10H19N3O4 (245.1375)


Isoleucyl-Asparagine is a dipeptide composed of isoleucine and asparagine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Asparaginyl-Leucine

2-{[2-amino-1-hydroxy-3-(C-hydroxycarbonimidoyl)propylidene]amino}-4-methylpentanoate

C10H19N3O4 (245.1375)


Asparaginyl-Leucine is a dipeptide composed of asparagine and leucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Leucyl-Asparagine

2-[(2-Amino-1-hydroxy-4-methylpentylidene)amino]-3-(C-hydroxycarbonimidoyl)propanoate

C10H19N3O4 (245.1375)


Leucyl-Asparagine is a dipeptide composed of leucine and asparagine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Valyl-Gamma-glutamate

2-Amino-4-[(2-amino-3-methylbutanoyl)-C-hydroxycarbonimidoyl]butanoate

C10H19N3O4 (245.1375)


Valyl-Gamma-glutamate is a dipeptide composed of valine and gamma-glutamate. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

3-Oxobutanoylcarnitine

3-[(3-oxobutanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C11H19NO5 (245.1263)


3-oxobutanoylcarnitine is an acylcarnitine. More specifically, it is an 3-oxobutanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-oxobutanoylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine 3-oxobutanoylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

[(1R,5R)-5-(6-Aminopurin-9-yl)cyclohex-3-en-1-yl]methanol

[(1R,5R)-5-(6-Aminopurin-9-yl)cyclohex-3-en-1-yl]methanol

C12H15N5O (245.1277)


   

(R)-2-(4-(Tert-butoxycarbonyl)morpholin-3-yl)acetic acid

(R)-2-(4-(Tert-butoxycarbonyl)morpholin-3-yl)acetic acid

C11H19NO5 (245.1263)


   

DL-Leucylglycylglycine

DL-Leucylglycylglycine

C10H19N3O4 (245.1375)


   

1,6-dihydro-6-imino-1,7-dimethyl-3-((E)-3-methylbuta-1,3-dienyl)-3H-purin-2(7H)-one|dioicine

1,6-dihydro-6-imino-1,7-dimethyl-3-((E)-3-methylbuta-1,3-dienyl)-3H-purin-2(7H)-one|dioicine

C12H15N5O (245.1277)


   

Oprea1_678420

Oprea1_678420

C11H19NO5 (245.1263)


   
   

(R)-lotaustralin

(R)-lotaustralin

C11H19NO5 (245.1263)


   
   

SCHEMBL18613826

SCHEMBL18613826

C10H19N3O4 (245.1375)


   
   
   
   
   
   
   

Leu-Gly-Gly

Leu-Gly-Gly

C10H19N3O4 (245.1375)


A tripeptide composed of one L-leucine and two glycine residues joined in sequence. CONFIDENCE standard compound; INTERNAL_ID 164

   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Asn-Ile

2-(2-amino-3-methylpentanamido)-3-carbamoylpropanoic acid

C10H19N3O4 (245.1375)


A dipeptide obtained by formal condensation of the carboxy group of L-asparagine with the amino group of L-isoleucine.

   

Asn-leu

2-(2-amino-4-methylpentanamido)-3-carbamoylpropanoic acid

C10H19N3O4 (245.1375)


   

GLN-Val

2-(2-amino-3-methylbutanamido)-4-carbamoylbutanoic acid

C10H19N3O4 (245.1375)


   

Ile-Asn

2-(2-amino-3-carbamoylpropanamido)-3-methylpentanoic acid

C10H19N3O4 (245.1375)


A dipeptide formed from L-isoleucine and L-asparagine residues.

   

Leu-asn

2-(2-amino-3-carbamoylpropanamido)-4-methylpentanoic acid

C10H19N3O4 (245.1375)


A dipeptide composed of L-leucine and L-asparagine joined by a peptide linkage.

   

Val-Gln

2-(2-amino-4-carbamoylbutanamido)-3-methylbutanoic acid

C10H19N3O4 (245.1375)


A dipeptide formed from L-valine and L-glutamine residues.

   

Val-gglu

2-[2-amino-4-(C-hydroxycarbonimidoyl)butanamido]-3-methylbutanoic acid

C10H19N3O4 (245.1375)


   

GGlu-Val

2-(2-amino-3-methylbutanamido)-4-(C-hydroxycarbonimidoyl)butanoic acid

C10H19N3O4 (245.1375)


   

N-[(2-fluorophenyl)methyl]-1-(4-methoxyphenyl)methanamine

N-[(2-fluorophenyl)methyl]-1-(4-methoxyphenyl)methanamine

C15H16FNO (245.1216)


   

4-Boc-3-Carboxymethylmorpholine

3-Carboxymethyl-morpholine-4-carboxylic acid tert-butyl ester

C11H19NO5 (245.1263)


   

DIETHYL 2-ACETAMIDO-2-ETHYLMALONATE

DIETHYL 2-ACETAMIDO-2-ETHYLMALONATE

C11H19NO5 (245.1263)


   

1-(4-fluorophenyl)-N-[(2-methoxyphenyl)methyl]methanamine

1-(4-fluorophenyl)-N-[(2-methoxyphenyl)methyl]methanamine

C15H16FNO (245.1216)


   

N-Phenyl-3-biphenylamine

N-Phenyl-3-biphenylamine

C18H15N (245.1204)


   

4-Methyl-2,5-diphenylpyridine

4-Methyl-2,5-diphenylpyridine

C18H15N (245.1204)


   

tert-Butyl 4-carbamothioylpiperazine-1-carboxylate

tert-Butyl 4-carbamothioylpiperazine-1-carboxylate

C10H19N3O2S (245.1198)


   

(2S,4S)-1-(tert-Butoxycarbonyl)-4-methoxypyrrolidine-2-carboxylic acid

(2S,4S)-1-(tert-Butoxycarbonyl)-4-methoxypyrrolidine-2-carboxylic acid

C11H19NO5 (245.1263)


   

(S)-2-(4-(tert-Butoxycarbonyl)morpholin-3-yl)acetic acid

(S)-2-(4-(tert-Butoxycarbonyl)morpholin-3-yl)acetic acid

C11H19NO5 (245.1263)


   

Gly-gly-ile

Glycylglycyl-l-isoleucine

C10H19N3O4 (245.1375)


A tripeptide composed of glycine, glycine and L-isoleucine residues joined in sequence.

   

TERT-BUTYL 3-(ETHOXYCARBONYL)-2-OXOPROPYLCARBAMATE

TERT-BUTYL 3-(ETHOXYCARBONYL)-2-OXOPROPYLCARBAMATE

C11H19NO5 (245.1263)


   

Gly-gly-leu

Gly-gly-leu

C10H19N3O4 (245.1375)


A tripeptide composed of glycine, glycine and L-leucine residues joined in sequence.

   

H-D-Leu-Gly-Gly-OH

H-D-Leu-Gly-Gly-OH

C10H19N3O4 (245.1375)


   

Pyridine,2-(diphenylmethyl)-

Pyridine,2-(diphenylmethyl)-

C18H15N (245.1204)


   

(2S,4R)-1-(tert-Butoxycarbonyl)-4-hydroxyhexahydro-2-pyridinecarboxylic acid

(2S,4R)-1-(tert-Butoxycarbonyl)-4-hydroxyhexahydro-2-pyridinecarboxylic acid

C11H19NO5 (245.1263)


   

1-(TERT-BUTOXYCARBONYL)-3-HYDROXYPIPERIDINE-4-CARBOXYLIC ACID

1-(TERT-BUTOXYCARBONYL)-3-HYDROXYPIPERIDINE-4-CARBOXYLIC ACID

C11H19NO5 (245.1263)


   

2-amino-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinonitrile

2-amino-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinonitrile

C12H16BN3O2 (245.1336)


   

1-Tert-butyl2-Methyl4-hydroxypyrrolidine-1,2-dicarboxylate

1-Tert-butyl2-Methyl4-hydroxypyrrolidine-1,2-dicarboxylate

C11H19NO5 (245.1263)


   

4-Boc-2-morpholineacetic acid

4-Boc-2-morpholineacetic acid

C11H19NO5 (245.1263)


   

(2S,4R)-1-(TERT-BUTOXYCARBONYL)-4-(HYDROXYMETHYL)PYRROLIDINE-2-CARBOXYLIC ACID

(2S,4R)-1-(TERT-BUTOXYCARBONYL)-4-(HYDROXYMETHYL)PYRROLIDINE-2-CARBOXYLIC ACID

C11H19NO5 (245.1263)


   

(4-FLUORO-BENZYL)-(4-METHOXY-BENZYL)-AMINE

(4-FLUORO-BENZYL)-(4-METHOXY-BENZYL)-AMINE

C15H16FNO (245.1216)


   

N-Phenyl-4-biphenylamine

N-Phenyl-4-biphenylamine

C18H15N (245.1204)


   

(2S,3R)-1-tert-Butyl 2-methyl 3-hydroxypyrrolidine-1,2-dicarboxylate

(2S,3R)-1-tert-Butyl 2-methyl 3-hydroxypyrrolidine-1,2-dicarboxylate

C11H19NO5 (245.1263)


   

Pyridine,4-(diphenylmethyl)-

Pyridine,4-(diphenylmethyl)-

C18H15N (245.1204)


   

2-hydroxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile

2-hydroxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile

C13H16BNO3 (245.1223)


   

6-Amino-4-cyanopyridine-3-boronic acid pinacol ester

6-Amino-4-cyanopyridine-3-boronic acid pinacol ester

C12H16BN3O2 (245.1336)


   

(R)-1-BOC-3-CARBOXYMETHOXY-PYRROLIDINE

(R)-1-BOC-3-CARBOXYMETHOXY-PYRROLIDINE

C11H19NO5 (245.1263)


   

1-Boc-3(S)-carboxymethoxy-pyrrolidine

1-Boc-3(S)-carboxymethoxy-pyrrolidine

C11H19NO5 (245.1263)


   

(S)-Tert-Butyl (1,5-diamino-1,5-dioxopentan-2-yl)carbamate

(S)-Tert-Butyl (1,5-diamino-1,5-dioxopentan-2-yl)carbamate

C10H19N3O4 (245.1375)


   

(S)-3-(TERT-BUTOXYCARBONYL)-2,2-DIMETHYLOXAZOLIDINE-4-CARBOXYLIC ACID

(S)-3-(TERT-BUTOXYCARBONYL)-2,2-DIMETHYLOXAZOLIDINE-4-CARBOXYLIC ACID

C11H19NO5 (245.1263)


   

(2S)-1-TERT-BUTYL 2-METHYL 5-HYDROXYPYRROLIDINE-1,2-DICARBOXYLATE

(2S)-1-TERT-BUTYL 2-METHYL 5-HYDROXYPYRROLIDINE-1,2-DICARBOXYLATE

C11H19NO5 (245.1263)


   

(R)-N-BOC-MORPHOLINE-2-ACETIC ACID

(R)-N-BOC-MORPHOLINE-2-ACETIC ACID

C11H19NO5 (245.1263)


   

(S)-N-BOC-MORPHOLINE-2-ACETIC ACID

(S)-N-BOC-MORPHOLINE-2-ACETIC ACID

C11H19NO5 (245.1263)


   

3-chloro-5-fluoroanisole

3-chloro-5-fluoroanisole

C15H16FNO (245.1216)


   

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine hydrochloride

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine hydrochloride

C11H21BClNO2 (245.1354)


   

5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazolo[3,4-b]pyridine

5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazolo[3,4-b]pyridine

C12H16BN3O2 (245.1336)


   

4-(N-Boc-amino)-3-oxo-pentanoic Acid Methyl Ester

4-(N-Boc-amino)-3-oxo-pentanoic Acid Methyl Ester

C11H19NO5 (245.1263)


   

Methyl 4-N-Boc-3-morpholinecarboxylate

Methyl 4-N-Boc-3-morpholinecarboxylate

C11H19NO5 (245.1263)


   

3-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[1,5-a]pyrimidine

3-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[1,5-a]pyrimidine

C12H16BN3O2 (245.1336)


   

(3-HYDROXYMETHYL-PYRROLIDIN-3-YL)-CARBAMICACIDTERT-BUTYLESTER

(3-HYDROXYMETHYL-PYRROLIDIN-3-YL)-CARBAMICACIDTERT-BUTYLESTER

C13H16BNO3 (245.1223)


   

Triphenylamine

Triphenylamine

C18H15N (245.1204)


   

(4-Isocyanatophenyl)boronic acid pinacol ester

(4-Isocyanatophenyl)boronic acid pinacol ester

C13H16BNO3 (245.1223)


   

GNF179 (Metabolite)

GNF179 (Metabolite)

C14H16FN3 (245.1328)


   

1-(tert-Butoxycarbonyl)-4-hydroxypiperidine-4-carboxylic acid

1-(tert-Butoxycarbonyl)-4-hydroxypiperidine-4-carboxylic acid

C11H19NO5 (245.1263)


   

Leucyl-glycyl-glycine

Leucyl-glycyl-glycine

C10H19N3O4 (245.1375)


   

4-[(4-Ethynylphenyl)ethynyl]-N,N-dimethylaniline

4-[(4-Ethynylphenyl)ethynyl]-N,N-dimethylaniline

C18H15N (245.1204)


   

Ac-Glu(OtBu)-OH

Ac-Glu(OtBu)-OH

C11H19NO5 (245.1263)


   

4-Boc-2-homomorpholinecarboxylic Acid

4-Boc-2-homomorpholinecarboxylic Acid

C11H19NO5 (245.1263)


   

(2S,3S)-1-(TERT-BUTOXYCARBONYL)-3-HYDROXYPYRROLIDINE-2-CARBOXYLICACIDMETHYLESTER

(2S,3S)-1-(TERT-BUTOXYCARBONYL)-3-HYDROXYPYRROLIDINE-2-CARBOXYLICACIDMETHYLESTER

C11H19NO5 (245.1263)


   

4-tert-Butyl 2-methyl morpholine-2,4-dicarboxylate

4-tert-Butyl 2-methyl morpholine-2,4-dicarboxylate

C11H19NO5 (245.1263)


   

3-CARBOXYMETHOXY-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

3-CARBOXYMETHOXY-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C11H19NO5 (245.1263)


   

1-(TERT-BUTOXYCARBONYL)-4-HYDROXYPIPERIDINE-2-CARBOXYLIC ACID

1-(TERT-BUTOXYCARBONYL)-4-HYDROXYPIPERIDINE-2-CARBOXYLIC ACID

C11H19NO5 (245.1263)


   

H-Gly-Leu-Gly-OH

N-(N-Glycyl-L-leucyl)glycine

C10H19N3O4 (245.1375)


   

(2S,4S)-1-tert-Butyl 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate

(2S,4S)-1-tert-Butyl 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate

C11H19NO5 (245.1263)


   

(1-CYANO-CYCLOHEPTYL)-CARBAMICACIDTERT-BUTYLESTER

(1-CYANO-CYCLOHEPTYL)-CARBAMICACIDTERT-BUTYLESTER

C10H23NO2Si2 (245.1267)


   

4-Amino-p-terphenyl

4-Amino-p-terphenyl

C18H15N (245.1204)


   
   

CHEMBRDG-BB 5534625

CHEMBRDG-BB 5534625

C15H16FNO (245.1216)


   

(R)-N-BOC-3-MORPHOLINEACETIC ACID

(R)-N-BOC-3-MORPHOLINEACETIC ACID

C11H19NO5 (245.1263)


   

1H-Benzo[d][1,2,3]triazol-5-ylboronic acid pinacol ester

1H-Benzo[d][1,2,3]triazol-5-ylboronic acid pinacol ester

C12H16BN3O2 (245.1336)


   

1-tert-butyl 3-methyl 3-hydroxypyrrolidine-1,3-dicarboxylate

1-tert-butyl 3-methyl 3-hydroxypyrrolidine-1,3-dicarboxylate

C11H19NO5 (245.1263)


   

(R)-methyl N-tert-butoxycarbonylmorpholine-3-carboxylate

(R)-methyl N-tert-butoxycarbonylmorpholine-3-carboxylate

C11H19NO5 (245.1263)


   

(2S,4S)-4-((TETRAHYDRO-2H-PYRAN-4-YL)METHYL)GLUTAMICACID

(2S,4S)-4-((TETRAHYDRO-2H-PYRAN-4-YL)METHYL)GLUTAMICACID

C11H19NO5 (245.1263)


   

N-[(3-fluorophenyl)methyl]-1-(4-methoxyphenyl)methanamine

N-[(3-fluorophenyl)methyl]-1-(4-methoxyphenyl)methanamine

C15H16FNO (245.1216)


   

4-N-Boc-Amino-4-carboxytetrahydropyran

4-N-Boc-Amino-4-carboxytetrahydropyran

C11H19NO5 (245.1263)


   

(2R,4R)-4-Hydroxy-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-2-piperidinecarboxylic acid

(2R,4R)-4-Hydroxy-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-2-piperidinecarboxylic acid

C11H19NO5 (245.1263)


   

2-CYANO-6-METHOXYPHENYL BORONIC ACID NEOPENTYL GLYCOL ESTER

2-CYANO-6-METHOXYPHENYL BORONIC ACID NEOPENTYL GLYCOL ESTER

C13H16BNO3 (245.1223)


   

2-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)-6-methoxybenzonitrile

2-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)-6-methoxybenzonitrile

C13H16BNO3 (245.1223)


   

1-Boc-5-Hydroxypiperidine-3-carboxylic Acid

1-Boc-5-Hydroxypiperidine-3-carboxylic Acid

C11H19NO5 (245.1263)


   

3-hydroxy-1,2-Piperidinedicarboxylic acid 1-(1,1-diMethylethyl) ester

3-hydroxy-1,2-Piperidinedicarboxylic acid 1-(1,1-diMethylethyl) ester

C11H19NO5 (245.1263)


   

N-Boc-cis-4-hydroxy-L-proline Methyl Ester

N-Boc-cis-4-hydroxy-L-proline Methyl Ester

C11H19NO5 (245.1263)


   

2-methyl-4,6-diphenylpyridine

2-methyl-4,6-diphenylpyridine

C18H15N (245.1204)


   

FMOC-L-4-TRIFLUOROMETHYLPHENYLALANINE

FMOC-L-4-TRIFLUOROMETHYLPHENYLALANINE

C13H16BNO3 (245.1223)


   

[1,2,4]triazolo[1,5-a]pyridine-6-boronic acid pinacol ester

[1,2,4]triazolo[1,5-a]pyridine-6-boronic acid pinacol ester

C12H16BN3O2 (245.1336)


   
   

Pyridine,3-(diphenylmethyl)-

Pyridine,3-(diphenylmethyl)-

C18H15N (245.1204)


   

N-Boc-cis-4-hydroxy-D-proline methyl ester

N-Boc-cis-4-hydroxy-D-proline methyl ester

C11H19NO5 (245.1263)


   

Boc-trans-D-Hyp-OMe

Boc-trans-D-Hyp-OMe

C11H19NO5 (245.1263)


   

N-Boc-3-MethylMorpholine-3-carboxylic Acid

N-Boc-3-MethylMorpholine-3-carboxylic Acid

C11H19NO5 (245.1263)


   

BoroGly-(+)-Pinanediol-HCl

BoroGly-(+)-Pinanediol-HCl

C11H21BClNO2 (245.1354)


   

CIS-3-BOC-AMINO-TETRAHYDROPYRAN-4-CARBOXYLIC ACID

CIS-3-BOC-AMINO-TETRAHYDROPYRAN-4-CARBOXYLIC ACID

C11H19NO5 (245.1263)


   

Glycyl-alanyl-valine

Glycyl-alanyl-valine

C10H19N3O4 (245.1375)


   

Glycine, L-alanyl-L-valyl-

Glycine, L-alanyl-L-valyl-

C10H19N3O4 (245.1375)


   
   

Asparaginyl-Leucine

Asparaginyl-Leucine

C10H19N3O4 (245.1375)


   

L-Valylglycyl-L-alanine

L-Valylglycyl-L-alanine

C10H19N3O4 (245.1375)


   

Glycine, L-isoleucylglycyl-

Glycine, L-isoleucylglycyl-

C10H19N3O4 (245.1375)


   

L-Valyl-L-alanylglycine

L-Valyl-L-alanylglycine

C10H19N3O4 (245.1375)


   

Methyl (3s)-3-[(Tert-Butoxycarbonyl)amino]-4-Oxopentanoate

Methyl (3s)-3-[(Tert-Butoxycarbonyl)amino]-4-Oxopentanoate

C11H19NO5 (245.1263)


   

4-(ethoxycarbonyl)-3,5-dimethyl-1-phenyl-1H-pyrazol-2-ium

4-(ethoxycarbonyl)-3,5-dimethyl-1-phenyl-1H-pyrazol-2-ium

C14H17N2O2+ (245.129)


   

Asparagylisoleucine

Asparagylisoleucine

C10H19N3O4 (245.1375)


   

L-Leucyl-L-asparagine

L-Leucyl-L-asparagine

C10H19N3O4 (245.1375)


   

L-Isoleucyl-L-asparagine

L-Isoleucyl-L-asparagine

C10H19N3O4 (245.1375)


   

(2S)-2-(2-carboxylatoethylamino)-5-(diaminomethylideneazaniumyl)pentanoate

(2S)-2-(2-carboxylatoethylamino)-5-(diaminomethylideneazaniumyl)pentanoate

C9H17N4O4- (245.125)


   
   
   
   

(R)-acetoacetylcarnitine

(R)-acetoacetylcarnitine

C11H19NO5 (245.1263)


   
   

4-(N-Maleimido)benzyltrimethylammonium

4-(N-Maleimido)benzyltrimethylammonium

C14H17N2O2+ (245.129)


   

Acremolin B

Acremolin B

C12H15N5O (245.1277)


An imidazopurine that is 4,5-dihydro-1H-imidazo[2,1-b]purine substituted by methyl, oxo, methyl, and isopropyl groups at positions 1, 4, 5, and 7, respectively. It is a natural product isolated from the deep-sea-derived fungus Aspergillus sp. SCSIO Ind09F01.

   

Glycyl-valyl-alanine

Glycyl-valyl-alanine

C10H19N3O4 (245.1375)


   

D-octopine(1-)

D-octopine(1-)

C9H17N4O4- (245.125)


An D-alpha-amino acid anion arising from deprotonation of the carboxy groups and protonation of the guanidino group of D-octopine.

   

N-Acetylglutamic acid diethyl ester

N-Acetylglutamic acid diethyl ester

C11H19NO5 (245.1263)


   

Leucylasparagine

Leucylasparagine

C10H19N3O4 (245.1375)


   

Glutaminylvaline

Glutaminylvaline

C10H19N3O4 (245.1375)


   

Valyl-Gamma-glutamate

Valyl-Gamma-glutamate

C10H19N3O4 (245.1375)


   

Gly-Gly-Ile zwitterion

Gly-Gly-Ile zwitterion

C10H19N3O4 (245.1375)


A tripeptide zwitterion resulting from the transfer of a proton from the carboxy group to the amino group of Gly-Gly-Ile. Major microspecies at pH 7.3.

   
   
   
   
   
   
   
   
   
   
   
   
   

7-isopropyl-1,5-dimethylimidazo[2,1-b]purin-4-one

7-isopropyl-1,5-dimethylimidazo[2,1-b]purin-4-one

C12H15N5O (245.1277)


   

6-imino-1,7-dimethyl-3-(3-methylbuta-1,3-dien-1-yl)purin-2-one

6-imino-1,7-dimethyl-3-(3-methylbuta-1,3-dien-1-yl)purin-2-one

C12H15N5O (245.1277)


   

6-imino-1,7-dimethyl-3-[(1e)-3-methylbuta-1,3-dien-1-yl]purin-2-one

6-imino-1,7-dimethyl-3-[(1e)-3-methylbuta-1,3-dien-1-yl]purin-2-one

C12H15N5O (245.1277)


   

[(2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxyethylidene)amino]acetic acid

[(2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxyethylidene)amino]acetic acid

C10H19N3O4 (245.1375)


   

(2s)-2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-3-(c-hydroxycarbonimidoyl)propanoic acid

(2s)-2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-3-(c-hydroxycarbonimidoyl)propanoic acid

C10H19N3O4 (245.1375)


   

8-isopropyl-1,5-dimethylimidazo[2,1-b]purin-4-one

8-isopropyl-1,5-dimethylimidazo[2,1-b]purin-4-one

C12H15N5O (245.1277)